Alto Neuroscience (ANRO) Stock Chart & Stock Price History → Urgent alert: open this for a huge profit potential (From Timothy Sykes) (Ad) Free ANRO Stock Alerts $11.81 +0.04 (+0.34%) (As of 06/7/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrends Alto Neuroscience Stock Price Performance5 Day Performance+4.42%1 Month Performance-19.11%3 Month Performance-14.17% Receive ANRO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Alto Neuroscience and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Weiss RatingsWho are Nvidia’s Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.I call these Nvidia’s “Silent Partners.” ANRO Stock Chart for Sunday, June, 9, 2024 ANRO Chart by TradingView Alto Neuroscience Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/07/2024$11.77$11.81+0.34%$11.85$11.4231,306 shs$316.43 million06/06/2024$11.52$11.77+2.17%$12.02$11.5637,404 shs$316.38 million06/05/2024$11.31$11.52+1.86%$11.53$10.90145,191 shs$309.66 million06/04/2024$11.00$11.31+2.82%$11.80$10.85126,976 shs$304.01 million06/03/2024$11.96$11.00-8.03%$12.31$10.96149,994 shs$295.68 million05/31/2024$12.00$11.96-0.33%$12.38$11.9263,664 shs$321.49 million Get the Latest News and Ratings for ANRO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Alto Neuroscience and its competitors with MarketBeat's FREE daily newsletter. 05/30/2024$12.54$12.00-4.31%$12.78$11.8262,993 shs$322.56 million05/29/2024$12.28$12.54+2.12%$12.58$12.0347,699 shs$337.13 million05/28/2024$12.92$12.28-4.95%$13.21$12.04136,649 shs$330.09 million05/27/2024$12.92$12.92$13.63$11.7798,300 shs$347.29 million05/24/2024$11.73$12.92+10.14%$13.63$11.7798,307 shs$347.29 million05/23/2024$12.29$11.73-4.56%$12.55$11.68188,595 shs$315.30 million05/22/2024$12.69$12.29-3.15%$12.66$12.29153,884 shs$330.36 million05/21/2024$12.40$12.69+2.34%$12.96$12.21165,140 shs$341.11 million05/20/2024$12.47$12.40-0.56%$12.77$12.1097,284 shs$333.31 million05/17/2024$12.82$12.47-2.73%$13.06$12.1789,015 shs$335.19 million05/16/2024$13.84$12.82-7.37%$14.07$12.4096,285 shs$344.60 million05/15/2024$14.18$13.84-2.36%$14.67$13.69121,223 shs$372.02 million05/14/2024$14.09$14.18+0.60%$14.52$13.6347,287 shs$381.08 million05/13/2024$13.49$14.09+4.45%$14.40$13.54115,324 shs$378.74 million05/10/2024$14.60$13.49-7.60%$14.83$13.4259,200 shs$362.67 million05/09/2024$13.88$14.60+5.19%$14.66$13.7643,621 shs$392.51 million05/08/2024$15.01$13.88-7.53%$14.90$13.6751,592 shs$373.09 million05/07/2024$14.30$15.01+4.97%$15.07$14.3282,216 shs$403.47 million05/06/2024$14.22$14.30+0.56%$14.77$13.80141,055 shs$384.38 million05/03/2024$14.40$14.22-1.25%$14.64$13.87114,893 shs$382.23 million05/02/2024$16.10$14.40-10.56%$16.13$14.4079,128 shs$387.07 million05/01/2024$15.51$16.10+3.80%$16.53$14.91130,016 shs$432.77 million04/30/2024$15.56$15.51-0.32%$15.94$15.2371,418 shs$416.91 million04/29/2024$14.18$15.56+9.73%$16.29$14.4266,236 shs$418.32 million04/26/2024$14.13$14.14+0.07%$14.16$13.9622,746 shs$380.08 million04/25/2024$14.20$14.13-0.49%$14.44$13.7644,944 shs$379.81 million04/24/2024$13.88$14.20+2.31%$14.35$13.7436,767 shs$381.70 million04/23/2024$13.61$13.88+1.98%$14.30$13.7085,381 shs$373.09 million04/22/2024$12.96$13.61+5.02%$13.70$12.8879,989 shs$365.84 million04/19/2024$13.54$12.96-4.28%$13.81$12.78235,741 shs$348.37 million04/18/2024$13.48$13.54+0.45%$13.63$13.1379,670 shs$363.96 million04/17/2024$13.54$13.48-0.44%$13.80$13.24155,358 shs$362.34 million04/16/2024$14.09$13.54-3.90%$14.14$13.4280,719 shs$363.96 million04/15/2024$14.27$14.09-1.26%$14.54$13.5358,209 shs$378.80 millionUrgent alert: open this for a huge profit potential (Ad)This groundbreaking technology that Tim calls “Inception” isn’t being talked about anywhere… not on Fox, Yahoo, or CNBC.See Tim’s instructions to make this remarkably simple trade right here04/12/2024$14.11$14.27+1.13%$14.40$13.8961,354 shs$383.58 million04/11/2024$14.06$14.11+0.36%$14.30$13.86100,180 shs$379.33 million04/10/2024$14.73$14.06-4.55%$15.20$13.90117,997 shs$377.93 million04/09/2024$14.21$14.73+3.66%$14.86$14.1274,237 shs$395.94 million04/08/2024$14.52$14.21-2.13%$15.03$13.9588,715 shs$381.97 million04/05/2024$14.09$14.52+3.05%$14.80$13.9278,159 shs$390.30 million04/04/2024$14.18$14.09-0.63%$14.57$13.85141,284 shs$378.74 million04/03/2024$14.11$14.18+0.50%$14.43$14.05142,868 shs$381.16 million04/02/2024$14.56$14.11-3.09%$15.27$13.75170,528 shs$379.28 million04/01/2024$15.35$14.56-5.15%$15.35$14.18276,298 shs$391.43 million03/29/2024$15.39$15.35-0.26%$16.67$15.34208,815 shs$412.61 million03/28/2024$16.78$15.39-8.28%$16.83$15.39208,812 shs$413.68 million03/27/2024$17.90$16.78-6.26%$18.31$16.66162,716 shs$451.05 million03/26/2024$16.65$17.90+7.51%$18.35$16.95243,411 shs$481.15 million03/25/2024$15.97$16.65+4.26%$17.76$15.90261,112 shs$447.55 million03/22/2024$15.09$15.97+5.83%$16.35$14.84349,982 shs$408.35 million03/21/2024$15.03$15.09+0.40%$15.71$14.77270,904 shs$385.91 million03/20/2024$14.39$15.03+4.45%$15.67$13.97477,901 shs$384.32 million03/19/2024$14.16$14.39+1.62%$15.18$14.02448,933 shs$367.95 million03/18/2024$15.81$14.16-10.44%$15.86$13.60342,335 shs$362.07 million03/15/2024$14.90$15.81+6.11%$16.00$14.62804,117 shs$404.26 million03/14/2024$14.20$14.90+4.93%$15.33$13.85285,100 shs$380.99 million03/13/2024$14.54$14.20-2.34%$14.70$13.55263,754 shs$363.09 million03/12/2024$14.52$14.54+0.14%$15.04$13.93126,115 shs$371.79 million03/11/2024$13.76$14.52+5.52%$15.00$14.00137,369 shs$371.28 million03/08/2024$14.14$13.76-2.69%$15.05$13.52220,850 shs$351.84 million Related Companies: MannKind Stock Chart Calliditas Therapeutics AB (publ) Stock Chart Day One Biopharmaceuticals Stock Chart AbCellera Biologics Stock Chart Mirum Pharmaceuticals Stock Chart Prothena Stock Chart Collegium Pharmaceutical Stock Chart Enliven Therapeutics Stock Chart Cassava Sciences Stock Chart Arcturus Therapeutics Stock Chart Receive ANRO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Alto Neuroscience and its competitors with MarketBeat's FREE daily newsletter. This page (NYSE:ANRO) was last updated on 6/9/2024 by MarketBeat.com Staff From Our PartnersBreaking - The US Gov. Seized CITGODo you want an investment that can double or triple your money in the next three months? The US Court is cu...Augury Research | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredUrgent alert: open this for a huge profit potentialThis groundbreaking technology that Tim calls “Inception” isn’t being talked about anywhere… not on Fox, Yahoo...Timothy Sykes | SponsoredWho are Nvidia’s Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.Weiss Ratings | SponsoredAre You Positioned For The New Energy Goldrush?Open AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredRSVP: Charles Payne’s Cash Flow WorkshopDid you know you could "cash flow" the stocks in your portfolio? Without selling a single share of stock? ...Unstoppable Prosperity | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alto Neuroscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alto Neuroscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.